Empagliflozin in Cirrhosis (EmC) Safety Study: A safety and pharmacokinetic study
Latest Information Update: 20 Oct 2020
At a glance
- Drugs Empagliflozin (Primary)
- Indications Liver cirrhosis; Portal hypertension
- Focus Adverse reactions
- Acronyms EcM Safety Study
- 20 Oct 2020 New trial record